drugset
drugset / Trial / NCT02455856

Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male Participants

NCT02455856 ↗

Phase 1 Completed 16 enrolled Janssen Cilag N.V./S.A.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the effects of repeated once daily administration of 200 milligram (mg) of itraconazole (steady state) on the single-dose pharmacokinetics of JNJ 42847922 in healthy, male participants.

Timeline

Start
2015-05-18
Primary completion
2015-06-19
Completion
2015-06-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg —
Subject Seltorexant Small molecule 5 mg Oral

Indications

No indication recorded.